Considerations on Top Down Proteomics – Development of Diagnosis Tests for Patient

7th Annual Brasilian Symposium on Clinical & Pharmaceutical Solutions through Analysis (CPSA BRASIL 2020)

Proteomics Session Coordinator – CPSA Brazil 2020
Rafael Melani, Ph.D. from Northwestern University

“The development of new technology… of one specific protein can (lead to a) new diagnostic test.”

A passionate explanation of the love to help develop science and methodologies, even in little steps, to increase understanding of human disease with relevant biological knowledge. Technology continues to improve, and Top Down Proteomics (analysis of intact proteins) has developed into a technique that can be used to identify proteins that are involved with complex diseases, such as Cancer described in this CPSA Everyday. Much like people in society, proteins interact in networks working together, or possibly not working in unison. Understanding the complex protein networks help identify disease pathways that lead towards improved health outcomes for patients – with improved data to build relevant biological knowledge.

Proteomics Session Coordinator – Rafael Melani, PhD

Prof. Gilberto Domont, Emeritus Professor, Universidade Federal do Rio de Janeiro

Luca Fornelli, Ph.D, Assistant Professor of Biology, The University of Oklahoma, OK

Roundtable Contributors
Carlos Kiffer, MD, Ph.D.
Marc Chalom